Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2022

08.10.2021 | UNM CLINICAL CASE CONFERENCES

A Transient Treatable Tumor of the Pancreas

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

A 64-year-old male was evaluated in the emergency department with a 2-week history of jaundice, dark urine, and pale stools. He also reported a 25 lb. unintentional weight loss over the previous 3 months but had no other symptoms. His medical history included hyperlipidemia, obstructive sleep apnea, and allergic rhinitis; his surgical history and family history were negative. His social history included smoking cigarettes, 1 pack per day for 11 years, but he denied any use of alcohol or illicit drugs. His physical examination was unremarkable apart from scleral icterus and jaundice. At no point had salivary glands been enlarged. …
Literatur
2.
Zurück zum Zitat Sarles H, Sarles JC, Camatte R, Muratore R et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut. 1965;6:545–559.CrossRef Sarles H, Sarles JC, Camatte R, Muratore R et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut. 1965;6:545–559.CrossRef
4.
Zurück zum Zitat Schneider A, Michaely H, Weiss C, Hirth M et al. Prevalence and incidence of autoimmune pancreatitis in the population living in the Southwest of Germany. Digestion. 2017;96:187–198.CrossRef Schneider A, Michaely H, Weiss C, Hirth M et al. Prevalence and incidence of autoimmune pancreatitis in the population living in the Southwest of Germany. Digestion. 2017;96:187–198.CrossRef
5.
Zurück zum Zitat Sah RP, Pannala R, Chari ST, Sugumar A et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91–96.CrossRef Sah RP, Pannala R, Chari ST, Sugumar A et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91–96.CrossRef
6.
Zurück zum Zitat Chari ST, Kloeppel G, Zhang L, Notohara K et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;3:549–554.CrossRef Chari ST, Kloeppel G, Zhang L, Notohara K et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;3:549–554.CrossRef
7.
Zurück zum Zitat Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010;45:787–793.CrossRef Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010;45:787–793.CrossRef
8.
Zurück zum Zitat Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–1127.CrossRef Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–1127.CrossRef
9.
Zurück zum Zitat Deshpande V, Chicano S, Finkelberg D, Selig M et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–1545.CrossRef Deshpande V, Chicano S, Finkelberg D, Selig M et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–1545.CrossRef
10.
Zurück zum Zitat Okamoto A, Watanabe T, Kamata K, Minaga K, Kudo M. Recent updates on the relationship between cancer and autoimmune pancreatitis. Intern Med. 2019;58:1533–1539.CrossRef Okamoto A, Watanabe T, Kamata K, Minaga K, Kudo M. Recent updates on the relationship between cancer and autoimmune pancreatitis. Intern Med. 2019;58:1533–1539.CrossRef
11.
Zurück zum Zitat Masamune A, Kikuta K, Hamada S, Tsuji I et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020;55:462–470.CrossRef Masamune A, Kikuta K, Hamada S, Tsuji I et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020;55:462–470.CrossRef
13.
Zurück zum Zitat Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol. 2010;3:491–504.PubMedPubMedCentral Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol. 2010;3:491–504.PubMedPubMedCentral
14.
Zurück zum Zitat Kamisawa T, Chari ST, Giday SA, Kim M-H et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011;40:809–814.CrossRef Kamisawa T, Chari ST, Giday SA, Kim M-H et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011;40:809–814.CrossRef
15.
Zurück zum Zitat Yoon SB, Moon S-H, Kim JH, Song TJ, Kim M-H. The use of immunohistochemistry for IgG4 in the diagnosis of autoimmune pancreatitis: a systematic review and meta-analysis. Pancreatology. 2020;20:1611–1619.CrossRef Yoon SB, Moon S-H, Kim JH, Song TJ, Kim M-H. The use of immunohistochemistry for IgG4 in the diagnosis of autoimmune pancreatitis: a systematic review and meta-analysis. Pancreatology. 2020;20:1611–1619.CrossRef
16.
Zurück zum Zitat Chang MC, Liang PC, Jan S, Yang CY et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14:366–372.CrossRef Chang MC, Liang PC, Jan S, Yang CY et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14:366–372.CrossRef
17.
Zurück zum Zitat Takahashi M, Fujinaga Y, Notohara K, Koyama T et al. Diagnostic imaging guide for autoimmune pancreatitis. Jpn J Radiol 2020;38:591–612.CrossRef Takahashi M, Fujinaga Y, Notohara K, Koyama T et al. Diagnostic imaging guide for autoimmune pancreatitis. Jpn J Radiol 2020;38:591–612.CrossRef
19.
Zurück zum Zitat Buscarini E, De Lisi S, Arcidiacono PG, Petrone MC et al. Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol. 2011;17:2080–2085.CrossRef Buscarini E, De Lisi S, Arcidiacono PG, Petrone MC et al. Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol. 2011;17:2080–2085.CrossRef
20.
Zurück zum Zitat Noguchi K, Nakai Y, Mizuno S, Hirano K et al. Role of endoscopic ultrasonography-guided fine needle aspiration/biopsy in the diagnosis of autoimmune pancreatitis. Diagnostics (Basel). 2020;10:954.CrossRef Noguchi K, Nakai Y, Mizuno S, Hirano K et al. Role of endoscopic ultrasonography-guided fine needle aspiration/biopsy in the diagnosis of autoimmune pancreatitis. Diagnostics (Basel). 2020;10:954.CrossRef
21.
Zurück zum Zitat Okazaki K, Chari ST, Frulloni L, Lerch MM et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17:1–6.CrossRef Okazaki K, Chari ST, Frulloni L, Lerch MM et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17:1–6.CrossRef
22.
Zurück zum Zitat Masamune A, Nishimori I, Kikuta K, Tsuji I et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487–494.CrossRef Masamune A, Nishimori I, Kikuta K, Tsuji I et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487–494.CrossRef
23.
Zurück zum Zitat Soliman H, Vullierme M-P, Maire F, Hentic O et al. Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective. United Eur Gastroenterol J. 2019;7:1073–1083.CrossRef Soliman H, Vullierme M-P, Maire F, Hentic O et al. Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective. United Eur Gastroenterol J. 2019;7:1073–1083.CrossRef
Metadaten
Titel
A Transient Treatable Tumor of the Pancreas
Publikationsdatum
08.10.2021
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07261-2

Weitere Artikel der Ausgabe 1/2022

Digestive Diseases and Sciences 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.